Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.
about
Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporterTwo putative subunits of a peptide pump encoded in the human major histocompatibility complex class II regionPolymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complexHuman major histocompatibility complex contains a new cluster of genes between the HLA-D and complement C4 lociLack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNAImmunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseDiscrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products.The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognitionThe role of MHC class I allele Mamu-A*07 during SIV(mac)239 infectionSecretion and cell surface expression of IgG1 are impaired in human B lymphoblasts that lack HLA-A, -B, and -C antigens.Insulin binding to human B lymphoblasts is a function of HLA haplotype.Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.Chinese origin rhesus macaque major histocompatibility complex class I molecules promiscuously present epitopes from SIV associated with molecules of Indian origin; implications for immunodominance and viral escape.Construction of a map of the short arm of human chromosome 6Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7.Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytesAbnormal class I assembly and peptide presentation in the nonobese diabetic mouse.Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2)Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome.Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis.A gene required for class II-restricted antigen presentation maps to the major histocompatibility complexAn endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-SPeptide-induced stabilization and intracellular localization of empty HLA class I complexes.Class I molecules retained in the endoplasmic reticulum bind antigenic peptidesLoss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.T cell recognition of an HLA-A2-restricted epitope derived from a cleaved signal sequence.Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter.The protease inhibitor, N-acetyl-L-leucyl-L-leucyl-leucyl-L-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum.The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope.Expression of a human cytomegalovirus receptor correlates with infectibility of cells.Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells.Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6.Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex.New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapyTransfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells.Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules.Formation of a major histocompatibility complex class I tapasin disulfide indicates a change in spatial organization of the peptide-loading complex during assembly.Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7.Induction of assembly of MHC class I heavy chains with beta 2microglobulin by interferon-gamma.
P2860
Q24336610-7EB8C62B-7106-4670-B8E5-12955E9685F5Q24560017-C26F98E4-A22F-4CD8-BB97-04266BD30F15Q24563039-F146A43D-5E21-41AE-8245-9706B33D57C9Q24594760-73D0061F-8897-45B7-8E9D-0E2199A92541Q24601273-8B2ACF46-7D4B-430B-A440-659E06036D54Q28238379-B079A9E5-E27E-452C-A084-3E64E6F1BBFEQ30685494-1BFB65EA-FBEB-4562-93E2-815092FB8DEDQ33929340-BD28CDED-42DF-4039-8EBC-808E4FBBD69BQ33952695-C385F246-F54D-40A5-8F05-11C7A9C5D66CQ34313145-1933E926-0D57-470F-B5AE-01D3BD22ADE3Q34601831-481C8033-9B88-454F-AE23-A6B743949827Q34642305-6D9FF684-CB58-43CC-B34B-91D5665B9478Q35165056-F646F7D1-4E51-49FB-B628-4172CF20D368Q35608703-1AFD90E2-3830-4E6C-BC4B-5372AD486F5EQ35772675-6B74F254-2202-487F-82A0-837A4F6B4078Q35837639-847712BE-FAFA-4755-811F-B6AA3AD33F93Q35897578-8D52DD70-3B77-4EAA-8688-D7999210F106Q35999694-B1DBB4FB-98D7-44D9-AD73-901A99F48291Q36027129-A34E3895-306C-4BE7-AB8D-5D5FAFBFAC77Q36230273-6095BE68-9AEA-419D-B475-55C8A577C975Q36230650-A7B08EA5-0F64-4383-90CF-B768B781B825Q36231070-8BCEB535-00FE-42CC-8A26-83E3BBE0A5D1Q36231485-5B721880-DF08-4C25-B732-7C0820DB4D1DQ36361858-4BA30BE4-323B-4E8B-BD84-5613B4B86E93Q36362670-68C35828-3800-4B4F-8E3F-43EC464594A8Q36364011-6F18A5BD-3D9C-406F-AADD-A411121BC72AQ36364703-45770219-0AA7-4164-B006-809F30A177B1Q36366523-4A5E6880-6F07-4361-B246-65F724FB0DF6Q36401780-658F35AF-B720-45CE-93BF-5D342DBF3688Q36694813-73FE2654-416A-4572-A797-1B075B1C718DQ36911894-D678594D-0BBE-4507-898F-3D5C2219B0DCQ37393110-1803A501-25B4-49EF-8F4D-AB9E9B94A896Q37407789-3D862A16-BCCA-47FE-B2F2-A31A46F318B2Q37435333-F37D1B7F-ECF0-4517-B9EC-5D1FEAEC6B8AQ37481068-7796205F-6E0E-44FC-AAE3-DCF76CD65FEAQ39509568-D2B45DB5-593C-4C32-966C-3B696064E71CQ39597900-98803238-6AB0-45FD-9849-18207281B55FQ40044492-906C6E8D-4719-4987-921D-8FDBF502E1BAQ40252793-8ED3689D-5CE8-4232-8D92-3FD85F47C695Q40817169-4E9A4797-AE90-4E0C-8382-1CE56E714582
P2860
Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.
@en
Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.
@nl
type
label
Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.
@en
Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.
@nl
prefLabel
Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.
@en
Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.
@nl
P2093
P2860
P356
P1476
Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.
@en
P2093
J Petersen
J Strandtmann
R Rudersdorf
P2860
P304
P356
10.1073/PNAS.82.23.8183
P407
P577
1985-12-01T00:00:00Z